Market News / Story
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $69.47, Implies 10% Downside
·
According to estimates from 15 analysts, 10x Genomics, Inc. stock's average price target has risen from $67.47 to $69.47, with forecasts ranging from $40 to $110 per share Based on the Oct. 8 closing price, the updated target implies approximately 10% potential downside Consensus rating remains at “Buy” across 18 covering analysts, with 6 Buys, 11 Holds and 1 Sells Explore more price target data and ratings for 10x Genomics, Inc. on the Forecasts tab , and track all…